A Case of Essential Thrombocythemia Presenting as Esophageal Varix Bleeding and Multiple Thrombosis

식도정맥류 출혈과 다발성 혈전증으로 발견된 본태성 혈소판 증다증 1예

  • Yoon, So-Yeon (Division of Hemato-oncology, Department of Internal medicine, School of Medicine, Catholic University of Daegu) ;
  • Choi, Jun-Hyeok (Division of Hemato-oncology, Department of Internal medicine, School of Medicine, Catholic University of Daegu) ;
  • Kang, Sun-Mi (Division of Hemato-oncology, Department of Internal medicine, School of Medicine, Catholic University of Daegu) ;
  • Cho, Jung-Nam (Division of Hemato-oncology, Department of Internal medicine, School of Medicine, Catholic University of Daegu) ;
  • Bae, Sung-Hwa (Division of Hemato-oncology, Department of Internal medicine, School of Medicine, Catholic University of Daegu) ;
  • Ryoo, Hun-Mo (Division of Hemato-oncology, Department of Internal medicine, School of Medicine, Catholic University of Daegu)
  • 윤소연 (대구가톨릭대학교 의과대학 혈액종양학교실) ;
  • 최준혁 (대구가톨릭대학교 의과대학 혈액종양학교실) ;
  • 강선미 (대구가톨릭대학교 의과대학 혈액종양학교실) ;
  • 조정남 (대구가톨릭대학교 의과대학 혈액종양학교실) ;
  • 배성화 (대구가톨릭대학교 의과대학 혈액종양학교실) ;
  • 류헌모 (대구가톨릭대학교 의과대학 혈액종양학교실)
  • Published : 2011.06.30

Abstract

Essential thrombocythemia (ET), a subcategory of chronic myeloproliferative disorder, is characterized by absolute thrombocytosis due to excessive clonal proliferation of platelets, hyperaggregability of platelets, and increased incidence of thrombosis and hemorrhage. We consider a diagnosis of ET when an unexplained and persistent thrombocytosis is observed. It is difficult to consider ET first when we meet a patient with esophageal varix bleeding or unusual multiple thromboses like mesenteric vein, splenic vein, and portal vein. This article reports a patient who presented initially with esophageal varix bleeding and unusual multiple thromboses, thereafter, she was diagnosed with ET after testing positive for the Janus Tyrosine Kinase 2 (JAK2) V617F mutation. In conclusion, in patients with varix bleeding and unusual multiple thromboses, myeloproliferative disorders like essential thrombocythemia should be considered as a potential cause and testing for the JAK2 mutation is warranted.

Keywords